Indianapolis-based Algaeon Inc. has inked a multi-million dollar deal with a Florida company. The agreement calls for the Algaeon to supply algae for Valensa International LLC. September 12, 2013
INDIANAPOLIS, Ind. – Algaeon Inc., (Indianapolis, IN) today announced the signing of a multi-year, multi-million dollar supply agreement with Valensa International (Eustis, Florida) which provides high value “condition specific” nutraceuticals to the marketplace. Algaeon, in cooperation with Valensa, is using its extensive knowledge of algae production to bring a new level of efficiency and quality for algae-based ingredient supply to the nutraceutical market. Algaeon will develop manufacturing processes and technology while Valensa will produce finished form condition specific products that will be sold to marketers with recognized brands.
“Algaeon is thrilled to be working together with Valensa, a global leader in nutraceutical formulation for the human supplement market, and we are looking forward to bringing our exciting technology to the market,” said Paul DeLacey Chairman & CEO, Algaeon Inc. “We are confident that our combined strengths will allow us to move quickly and make a significant impact on the 'condition specific' nutraceutical market.”
According to Dr. Rudi E. Moerck, President and CEO of Valensa, the algae technology relationship with Algaeon provides a significant additional supplier of algae biomass and extracts to Valensa to allow the company to grow its portfolio of advanced condition specific products. “Valensa is a rapidly growing nutraceutical company with a thriving astaxanthin-based, condition-specific formulation business,” said Moerck. “We are excited and confident that this collaboration with Algaeon will provide additional algae sourced ingredients to Valensa to ultimately expand its offerings beyond Spirulina and Astaxanthin. We share Algaeon's vision and commitment to delivering high quality algae products for improved human health to the market,” he added.
About Algaeon Inc.
Algaeon Inc., an Indianapolis based biotech company, is manufacturing high value algae-based products for leading companies in the Nutraceutical and Animal / Fish Feed Supplement markets using its patent-pending cultivation technology. Algaeon is developing its own cultivation capacity, as well as, potentially licensing the technology for algae farms. For more information about Algaeon visit www.algaeon-inc.com.
About Valensa International
Headquartered in Eustis, Florida USA (near Orlando), Valensa International is a leading science-based developer and provider of high quality nature-sourced products for nutritional supplements and functional foods. Valensa's certified organic production facilities are located in a protected pine/saw palmetto grove. Valensa is a subsidiary of EID Parry (India) Ltd., the bioproducts and nutraceutical division of the Murugappa Group.
Valensa's condition specific products include Cran-Gyn Women's Health Formula, Pink Factor Breast Health Formula, Go Easy Policosanol Micro-dispersion, Flex Pro ES and Flex Pro MD joint health formulations and Eye Pro MD eye health formulation. Branded ingredients include Zanthin Natural Astaxanthin, Zanthin XP-3 Astaxanthin with ALA, SpiruZan Spirulina & Astaxanthin Complex, USPlus Prostate Formula and US Plus Rosso Saw Palmetto Extracts, Parry Organic Spirulina and Pur-Blue SpiruZan and Parry Tomato Lycopene Complex. Valensa Omega-3 brands include Tresalbio Supercritical Chia Seed Extract ChiaGold Stabilized Chia Seed Oil, , Z-Omega 3-6-9, Cranberol Cranberry Seed Extract and AstaCran Astaxanthin-Cranberry Seed Extract, along with its new Deep Ocean Krill and Verilla, Z-Omega 3-6-9 and Kerilla Perilla Seed Extract products. Functional food brands include Verilla Max and ChiaMax Omega-3 Low-Fat Whole Grain products. Valensa is committed to production and processing that supports the environment and fair labor practices for those that work the land and participate in the production process. For more information, visit www.valensa.com.
Source: Algaeon Inc.